TJ Cradick Speaks About Their HIV CRISPR Therapy in Trials

FromCRISPR Cuts

Start listening View podcast show

TJ Cradick Speaks About Their HIV CRISPR Therapy in Trials

FromCRISPR Cuts

ratings:

Length:

24 minutes

Released:

Mar 31, 2022

Format:

Podcast episode

Description

TJ Cradick, Chief Scientific Officer at Excision Bio, discusses their CRISPR HIV therapy that recently proceeded into clinical trials in this episode and their ongoing work on other viral diseases.

Released:

Mar 31, 2022

Format:

Podcast episode

Titles in the series (32)

Welcome to the CRISPR revolution. Take a break and join us as we guide conversations with an expert CRISPR cast about this cutting-edge science.

Skip carousel

Reed Kelso Strives to Enable CRISPR Access For All Scientists: Reed Kelso, Head of Cell Engineering Research and Applications at Synthego, is a bio-wizard. In this episode, Kevin & Minu catch up with Reed about his role at Synthego and the day-to-day operations at the fast paced start-up. Reed talks about the revolu... by CRISPR Cuts
16 min listen
The Potential of CRISPR Editing in Stem Cells: An Interview with Bill Skarnes: Dr. Bill Skarnes, Professor at The Jackson Laboratory, chats about how CRISPR edited stem cells are becoming a gold standard to study gene function and disease modeling. by CRISPR Cuts
13 min listen
CRISPR in Gene Drives: Experts Opine: Gene drives have frequently been in the news in the past few years. In this episode, we discuss what exactly gene drives are, their applications, and how scientists are ensuring that they are used responsibly. Tune in to hear what researchers Anna Buchma... by CRISPR Cuts
11 min listen
CRISPR for Curious Minds by CRISPR Cuts
41 min listen
Knockout Cell Pools Are Simplifying CRISPR Experiments: Dr. Ania Wronski, Product Manager for the Engineered Cells portfolio at Synthego, discusses how their new engineered cells products are enabling CRISPR access to researchers worldwide. Learn about the different ways in which researchers use knockout cell... by CRISPR Cuts
21 min listen
Making of a CRISPR Film: Behind the Scenes with Producers of Human Nature: What is the process to make a science film? In this episode, Sarah Goodwin and Elliot Kirschner, producers of Human Nature, a documentary on CRISPR, offer glimpses into making of the film. by CRISPR Cuts
38 min listen
CRISPR in Fungi: An Interview with Rebecca Shapiro: Rebecca Shapiro, Assistant Professor at the University of Guelph, talks about CRISPR genome editing in fungal pathogens to understand their disease-causing mechanism. Her lab also works on gene drives in fungi for studying large scale genetic interaction... by CRISPR Cuts
18 min listen
Avery Posey Discusses CAR T Cell Cancer Therapies: Dr. Avery Posey is leading the charge on CAR T cell therapy research to bring this technology to cancer patients as soon as possible. Learn how CAR T works, what stage it’s in now, and how it will help revolutionize the treatment of cancer. by CRISPR Cuts
25 min listen
Improving Targeted Delivery to Enhance Personalized Medicine: Andre Watson, CEO of Ligandal, talks about how his company is improving the payload delivery of gene therapy, making it more accurate and efficient, to make new gene therapy a reality for the public. by CRISPR Cuts
28 min listen
Alex Philippidis Reviews Trends in Biopharma & Biotech Market: Biotech and biopharma companies are in a phase of accelerated growth. Alex Philippidis, a science journalist at Genetic Engineering & Biotechnology News discusses the changing face of big pharma, biotech, and CRISPR gene editing industries, as they raise... by CRISPR Cuts
28 min listen
Neville Sanjana Discusses Ways to Enhance CRISPR-Cas13 Knockdown in Human Cells: In this collaboration episode with NEB, we interview Dr. Neville Sanjana, a core faculty member at the New York Genome Center, about his recent publication in which chemically modified guide RNAs were used to enhance CRISPR-Cas13 knockdown in human cells... by CRISPR Cuts
33 min listen
NIH Scientists Discuss the iNDI Project for Alzheimer's Disease Modeling: The Inducible Pluripotent Stem Cell Neurodegeneration Initiative (iNDI), an NIH effort, aims to standardize disease models for Alzheimer’s and related dementias. Hear the principal contributors, Dr. Michael E. Ward and Dr. Mark R. Cookson, scientists at ... by CRISPR Cuts
37 min listen
Leading St. Jude's Genome Engineering Capabilities: A Chat with Shondra Miller: Shondra Miller shares her experience of starting a shared genome engineering resource at the St. Jude Children's Research Hospital. Learn more about her research projects and her views on the past, present, and future of the genome editing field in this ... by CRISPR Cuts
10 min listen
CRISPR Office Hours with Hamid Ghanadaan: The COVID-19 pandemic is a unique situation for lab scientists, many of whose work has come to a standstill. Hamid Ghanadaan, CEO of Linus, discusses the impact of COVID-19 on science and the next steps for scientists, based on their survey of >1000 scie... by CRISPR Cuts
36 min listen
Joe Miano Talks About Prime Editing in Mice: Prime editing is a new genome engineering tool that emerged just a couple of years back. Right from the get-go, this technology made waves as a potential alternative to CRISPR. Now, the first comparative study in mice is out. Dr. Joe Miano, Professor at ... by CRISPR Cuts
20 min listen
Kevin Davies Chats About His Latest Book "Editing Humanity": Kevin Davies, the executive editor of The CRISPR Journal, has closely watched the genetics space evolve over the last decades. His expertise and experience were the perfect foundation for his latest book "Editing Humanity: The CRISPR Revolution and the N... by CRISPR Cuts
32 min listen
Michael Friend Advocates For Diversity in CRISPR: In this episode, Michael Friend, CEO of Minority Coalition for Precision Medicine, discusses the lack of diversity in genome editing field and covers potential solutions for ensuring an inclusive future, particularly for black scientists. by CRISPR Cuts
19 min listen
CRISPR Forecast 2021 with Paul Dabrowski and Robert Deans: In this episode, Paul Dabrowski, CEO of Synthego, and Robert Deans, CSO of Synthego, discuss the CRISPR silver linings of 2020 and predict the directions and milestones for gene editing in 2021. by CRISPR Cuts
18 min listen
Kiana Aran Chats About her Nature Award and New Non-Profit: In this episode, we chat with Dr. Kiana Aran, the CSO of Cardea Bio and associate professor at Keck Graduate Institute, who recently won the Nature Research Award for Inspiring Women in Science. Dr. Aran talks about her experience being a nominee and awa... by CRISPR Cuts
41 min listen
6 Women CRISPR Leaders Get Candid About Their Journeys to the Top: We chatted with six female leaders in the CRISPR—Alison van Eenennaam, Ph.D., Kiana Aran, Christina Trojel-Hansen, Ph.D., Laura Lambert, Ph.D., Elena Miñones Moyano, Ph.D., and Samantha Maragh, Ph.D.— about their professional journeys. Tune in to this e... by CRISPR Cuts
63 min listen
Jesse Boehm Discusses Tackling Rare Cancers Using CRISPR: In this CRISPR Cuts episode, Dr. Jesse Boehm, the Chief Scientific Officer of the Break Through Cancer Foundation and principal investigator at the Broad Institute, talks about his work on rare cancers. He also covers how CRISPR technology is transformin... by CRISPR Cuts
31 min listen
Bryce Olson Relays His Experience on Personalized Therapies for Cancer Patients: After being diagnosed with aggressive prostate cancer, Bryce Olson quickly learned the science behind it and has leveraged NGS to understand his tumor genomics and find opportunities in personalized therapies. Hear the patient perspective for the first t... by CRISPR Cuts
43 min listen
Christian Groendahl On Pioneering a CRISPR-based Microbial Gene Therapy: Tune in to hear Christian Groendahl, CEO of SNIPR Biome, talk about CRISPR editing in prokaryotes, their novel E. coli-targeting CRISPR therapy trials, and his experiences and vision leading a start up. by CRISPR Cuts
29 min listen
TJ Cradick Speaks About Their HIV CRISPR Therapy in Trials: TJ Cradick, Chief Scientific Officer at Excision Bio, discusses their CRISPR HIV therapy that recently proceeded into clinical trials in this episode and their ongoing work on other viral diseases. by CRISPR Cuts
24 min listen
Bryan Dechairo Envisions an Accessible Future for CRISPR Diagnostics: In this episode, Bryan Dechairo, CEO of Sherlock Biosciences, talks about the impact of technology advances in the field of CRISPR diagnostics, his experiences leading Sherlock Biosciences, and his team’s mission of accessibility. by CRISPR Cuts
35 min listen
Ayal Hendel Talks About CRISPR in Bubble Boy Disease: Dr. Ayal Hendel, a genome-editing pioneer and group leader at Bar Ilan University in Israel, was one of the first researchers to use modified synthetic sgRNA to edit primary cells with CRISPR. In this episode, Dr. Hendel shares his perspectives on the re... by CRISPR Cuts
36 min listen
Imran House and Junyun Lai Discuss CRISPR Screening in Immuno-Oncology: Imran House, Ph.D. and Junyun Lai Ph.D. are Senior Scientists at the biotech start-up, ONKo-Innate in Melbourne, Australia that focuses on developing immuno-oncology therapies. In this episode they discussed what they do at oNKo-innate, their career ... by CRISPR Cuts
26 min listen
Jimi Olaghere Opens up About His Sickle Cell Disease and CRISPR Trial: Jimi has dealt with sickle cell disease, a genetic disorder with serious implications, his entire life. Undergoing a CRISPR gene editing trial turned his hope for a cure into reality with promising results from the early phases. Tune in to learn about Ji... by CRISPR Cuts
40 min listen
Stephanie Cherqui Discusses Clinical Development of CRISPR Therapies for Rare Diseases by CRISPR Cuts
20 min listen
Sunil Sharma and Raffaella Soldi Talk CRISPR For Unbiased Drug Screening for Rare Pediatric Cancers: Dr. Sunil Sharma and Dr. Raffaella Soldi of the Translational Genomics Research Institute chat about using CRISPR arrayed screens to identify novel drug targets for Ewing's Sarcoma, outlooks for the future of cancer therapies, and the Arizona heat. by CRISPR Cuts
25 min listen

More Episodes from CRISPR Cuts

Skip carousel

Imran House and Junyun Lai Discuss CRISPR Screening in Immuno-Oncology: Imran House, Ph.D. and Junyun Lai Ph.D. are Senior Scientists at the biotech start-up, ONKo-Innate in Melbourne, Australia that focuses on developing immuno-oncology therapies. In this episode they discussed what they do at oNKo-innate, their career ... by CRISPR Cuts
26 min listen
Mark DeWitt and Don Kohn Discuss Their ex vivo CRISPR-based Therapy to Cure Sickle Cell Anemia: Dr. Mark DeWitt Ph.D., Associate Director at Mammoth Biosciences, and Dr. Don Kohn M.D., distinguished professor and Director of the UCLA Human Gene and Cell Therapy Program and CIRM grantee sat down with us to discuss their latest clinical trials to... by CRISPR Cuts
33 min listen
Dina Simkin Breaks Down Epilepsy Cell Modeling: Dina Simkin, Professor of Neurology at Northwestern University, joins us in this episode of CRISPR Cuts. Dr. Simkin talks about her path to becoming a researcher, art, and the importance of patient and isogenic iPSC models to study genetically linked... by CRISPR Cuts
27 min listen
Sunil Sharma and Raffaella Soldi Talk CRISPR For Unbiased Drug Screening for Rare Pediatric Cancers: Dr. Sunil Sharma and Dr. Raffaella Soldi of the Translational Genomics Research Institute chat about using CRISPR arrayed screens to identify novel drug targets for Ewing's Sarcoma, outlooks for the future of cancer therapies, and the Arizona heat. by CRISPR Cuts
25 min listen
Stephanie Cherqui Discusses Clinical Development of CRISPR Therapies for Rare Diseases by CRISPR Cuts
20 min listen
Christian Groendahl On Pioneering a CRISPR-based Microbial Gene Therapy: Tune in to hear Christian Groendahl, CEO of SNIPR Biome, talk about CRISPR editing in prokaryotes, their novel E. coli-targeting CRISPR therapy trials, and his experiences and vision leading a start up. by CRISPR Cuts
29 min listen
Bryan Dechairo Envisions an Accessible Future for CRISPR Diagnostics: In this episode, Bryan Dechairo, CEO of Sherlock Biosciences, talks about the impact of technology advances in the field of CRISPR diagnostics, his experiences leading Sherlock Biosciences, and his team’s mission of accessibility. by CRISPR Cuts
35 min listen
Ayal Hendel Talks About CRISPR in Bubble Boy Disease: Dr. Ayal Hendel, a genome-editing pioneer and group leader at Bar Ilan University in Israel, was one of the first researchers to use modified synthetic sgRNA to edit primary cells with CRISPR. In this episode, Dr. Hendel shares his perspectives on the re... by CRISPR Cuts
36 min listen
Jimi Olaghere Opens up About His Sickle Cell Disease and CRISPR Trial: Jimi has dealt with sickle cell disease, a genetic disorder with serious implications, his entire life. Undergoing a CRISPR gene editing trial turned his hope for a cure into reality with promising results from the early phases. Tune in to learn about Ji... by CRISPR Cuts
40 min listen
Bryce Olson Relays His Experience on Personalized Therapies for Cancer Patients: After being diagnosed with aggressive prostate cancer, Bryce Olson quickly learned the science behind it and has leveraged NGS to understand his tumor genomics and find opportunities in personalized therapies. Hear the patient perspective for the first t... by CRISPR Cuts
43 min listen
Neville Sanjana Discusses Ways to Enhance CRISPR-Cas13 Knockdown in Human Cells: In this collaboration episode with NEB, we interview Dr. Neville Sanjana, a core faculty member at the New York Genome Center, about his recent publication in which chemically modified guide RNAs were used to enhance CRISPR-Cas13 knockdown in human cells... by CRISPR Cuts
33 min listen
Kiana Aran Chats About her Nature Award and New Non-Profit: In this episode, we chat with Dr. Kiana Aran, the CSO of Cardea Bio and associate professor at Keck Graduate Institute, who recently won the Nature Research Award for Inspiring Women in Science. Dr. Aran talks about her experience being a nominee and awa... by CRISPR Cuts
41 min listen
6 Women CRISPR Leaders Get Candid About Their Journeys to the Top: We chatted with six female leaders in the CRISPR—Alison van Eenennaam, Ph.D., Kiana Aran, Christina Trojel-Hansen, Ph.D., Laura Lambert, Ph.D., Elena Miñones Moyano, Ph.D., and Samantha Maragh, Ph.D.— about their professional journeys. Tune in to this e... by CRISPR Cuts
63 min listen
Jesse Boehm Discusses Tackling Rare Cancers Using CRISPR: In this CRISPR Cuts episode, Dr. Jesse Boehm, the Chief Scientific Officer of the Break Through Cancer Foundation and principal investigator at the Broad Institute, talks about his work on rare cancers. He also covers how CRISPR technology is transformin... by CRISPR Cuts
31 min listen
NIH Scientists Discuss the iNDI Project for Alzheimer's Disease Modeling: The Inducible Pluripotent Stem Cell Neurodegeneration Initiative (iNDI), an NIH effort, aims to standardize disease models for Alzheimer’s and related dementias. Hear the principal contributors, Dr. Michael E. Ward and Dr. Mark R. Cookson, scientists at ... by CRISPR Cuts
37 min listen
Joe Miano Talks About Prime Editing in Mice: Prime editing is a new genome engineering tool that emerged just a couple of years back. Right from the get-go, this technology made waves as a potential alternative to CRISPR. Now, the first comparative study in mice is out. Dr. Joe Miano, Professor at ... by CRISPR Cuts
20 min listen
Kevin Davies Chats About His Latest Book "Editing Humanity": Kevin Davies, the executive editor of The CRISPR Journal, has closely watched the genetics space evolve over the last decades. His expertise and experience were the perfect foundation for his latest book "Editing Humanity: The CRISPR Revolution and the N... by CRISPR Cuts
32 min listen
Michael Friend Advocates For Diversity in CRISPR: In this episode, Michael Friend, CEO of Minority Coalition for Precision Medicine, discusses the lack of diversity in genome editing field and covers potential solutions for ensuring an inclusive future, particularly for black scientists. by CRISPR Cuts
19 min listen
CRISPR Forecast 2021 with Paul Dabrowski and Robert Deans: In this episode, Paul Dabrowski, CEO of Synthego, and Robert Deans, CSO of Synthego, discuss the CRISPR silver linings of 2020 and predict the directions and milestones for gene editing in 2021. by CRISPR Cuts
18 min listen
CRISPR Office Hours with Hamid Ghanadaan: The COVID-19 pandemic is a unique situation for lab scientists, many of whose work has come to a standstill. Hamid Ghanadaan, CEO of Linus, discusses the impact of COVID-19 on science and the next steps for scientists, based on their survey of >1000 scie... by CRISPR Cuts
36 min listen
Making of a CRISPR Film: Behind the Scenes with Producers of Human Nature: What is the process to make a science film? In this episode, Sarah Goodwin and Elliot Kirschner, producers of Human Nature, a documentary on CRISPR, offer glimpses into making of the film. by CRISPR Cuts
38 min listen
Leading St. Jude's Genome Engineering Capabilities: A Chat with Shondra Miller: Shondra Miller shares her experience of starting a shared genome engineering resource at the St. Jude Children's Research Hospital. Learn more about her research projects and her views on the past, present, and future of the genome editing field in this ... by CRISPR Cuts
10 min listen
The Potential of CRISPR Editing in Stem Cells: An Interview with Bill Skarnes: Dr. Bill Skarnes, Professor at The Jackson Laboratory, chats about how CRISPR edited stem cells are becoming a gold standard to study gene function and disease modeling. by CRISPR Cuts
13 min listen
CRISPR in Fungi: An Interview with Rebecca Shapiro: Rebecca Shapiro, Assistant Professor at the University of Guelph, talks about CRISPR genome editing in fungal pathogens to understand their disease-causing mechanism. Her lab also works on gene drives in fungi for studying large scale genetic interaction... by CRISPR Cuts
18 min listen

Related podcast episodes

Skip carousel

Ep. 16: “T Cell Regulation” Featuring Dr. Dario Vignali: Dr. Dario Vignali is the Frank Dixon Chair in Cancer Immunology and Vice Chair and Professor of Immunology at University of Pittsburgh School of Medicine. His lab studies various aspects of T cell regulation, by The Immunology Podcast
70 min listen
Reopening After Coronavirus: Are We Ready?: Is it safe to emerge from COVID-19 isolation? WebMD Chief Medical Officer John Whyte, MD, talks to two experts -- former CDC Director Richard Besser, MD, and Vincent Racaniello, PhD, professor of microbiology and immunology at Columbia University --... by Health Discovered
24 min listen
The Cell Solution – Susan Stevenson, Executive Director, and Craig Mickanin, Director, Novartis – Gene Therapy Provides New Hope For Disease Treatment: Susan Stevenson, executive director, and Craig Mickanin, director, of the Swiss multinational pharmaceutical company, Novartis, based in Basel, Switzerland, deliver an informative overview of the incredible advances in gene therapy and transformative... by Finding Genius Podcast
25 min listen
Update in Clinical Infectious Diseases 2019-2020: This Clinical Review podcast reviews some of the most important advances in clinical infectious diseases presented at IDWeek 2019 including data on rapid testing, new antimicrobial agents, and new strategies for using existing antibiotics to manage... by JAMA Clinical Reviews
15 min listen
CBD (Cannabidiol), Antiviral Drugs, SARS-CoV-2 & Cancer Biology | Marsha Rosner | #59 by Mind & Matter
86 min listen
214. Small But Mighty - An Internist's Approach to Small Cell Lung Cancer by The Intern At Work: Internal Medicine
13 min listen
What’s new in Thoracic Surgery for lung cancer: Drs. Linda Martin (University of Virginia) and Dennis Wigle (Mayo Clinic) review recent clinical trial publications on sublobar resection for early stage lung cancer, and the use of immunotherapy before surgery for later stage (locally advanced) lung... by GTSC Podcast
55 min listen
43. The Eye of the Storm: In 2022, a mysterious outbreak of a deadly drug-resistant bacteria began spreading across several U.S. states. A CDC investigation would eventually reveal an unusual culprit: common eye drops. In this episode, Dr. Danielle Rankin takes us behind the... by Contagious Conversations
19 min listen
Episode 67: Careers in Infectious Diseases by Run the List
27 min listen
Episode 230: FGFR Inhibition in NMIBC With Sia Daneshmand by The Uromigos
26 min listen
Episode 71: Approach to Shock by Run the List
15 min listen
Predicting & Preventing Long-Haul Covid - with Dr. Heath & Dr. Su | EP 146 by The Empowering Neurologist Podcast
41 min listen
Gene Genie – George Church, Geneticist, Chemist, Molecular Engineer, Professor at Harvard and MIT – How Genome Sequencing and Gene Therapy Is Turning Fantasy Into Reality and Helping to Reverse Disease: George Church is an American geneticist, chemist, molecular engineer, professor of genetics at Harvard Medical School, and professor of health sciences and technology at Harvard and MIT. Church provides an informative and thorough overview of his work... by Finding Genius Podcast
38 min listen
Coronavirus (COVID-19) Update: Critical Care Management: Noninvasive ventilation (NIV), working with dying patients’ families, use of experimental therapies, and more. JAMA Associate Editor Derek Angus, MD, MPH, Distinguished Professor and Chair of Critical Care Medicine at the University of Pittsburgh,... by JAMA Author Interviews
46 min listen
Coronavirus (COVID-19) Update: Critical Care Management: Noninvasive ventilation (NIV), working with dying patients’ families, use of experimental therapies, and more. JAMA Associate Editor Derek Angus, MD, MPH, Distinguished Professor and Chair of Critical Care Medicine at the University of Pittsburgh,... by Coronavirus (COVID-19) Q&A
46 min listen
Individualizing HIV ART: Rapid Start: Listen to Daniel R. Kuritzkes, MD, discuss considerations for rapid start of antiretroviral therapy in patients newly diagnosed with HIV, including management of patients with a history of receiving PrEP. by CCO Infectious Disease Podcast
4 min listen
630: Mapping Our Genetic Make-Up in the Human Genome Project and Beyond - Dr. Eric Green: Dr. Eric Green is the Director of the National Human Genome Research Institute at the National Institutes of Health. Eric works in the field of genomics. Everything from cars to houses has a blueprint of information that defines its creation and... by People Behind the Science Podcast Stories from Scientists about Science, Life, Research, and Science Careers
51 min listen
Podcast #74 - BioHacking the Microbiome to Cure Disease - Induced Native Phage Therapy | Dr. David Jernigan: Dr. Sharon Stills interviews Dr. David Jernigan, innovator in Induced Native Phage Therapy and practitioner of Biological Medicine about a little known but extremely powerful method of treating disease. Did you know we have not only a microbiome, but... by The Science of Self-Healing
58 min listen
Inside the Issue: Targeted and Immunotherapeutic Approaches for Biliary Tract Cancers: Featuring a discussion of targeted and immunotherapeutic approaches for biliary tract cancers with Drs Lipika Goyal and Milind Javle, moderated by Dr Neil Love. Produced by Research To Practice. by Oncology Today with Dr Neil Love
60 min listen
Ep. 231: “Manipulating Stem Cell Fate” Featuring Dr. Shuibing Chen: Dr. Shuibing Chen is the Kilts Family Professor of Surgery at Weill Cornell Medicine. Her lab uses hiPSCs and ESCs for disease modeling and drug screening, with a focus on diabetes and infectious diseases such as Zika and SARS-CoV-2. by The Stem Cell Podcast
66 min listen
#32 – Iatrogenic infections related to anesthesia workstation behaviors – Chuck Biddle, PhD, CRNA: In this podcast, I talk with Chuck Biddle, PhD, CRNA about iatrogenic infections related to anesthesia workstation behaviors. This continues to be a focal point of Dr Biddle’s research on patient safety and is a topic that concerns every anesthesia…Re... by From the Head of the Bed
41 min listen
Response Assessment of Malignancies: Dr. Lisa Blacklock discusses a recent paper published in RadioGraphics titled “FDG PET/CT Based Response Assessment of Malignancies” by Dr. Ashwin Singh Parihar, Dr. Farrokh Dehdashti. by RadioGraphics Podcasts | RSNA
14 min listen
Episode 21: Science Commune: Inspiration and Growth from the Early Days of Microbiology by The Chain: Protein Engineering Podcast
17 min listen
Key HIV Studies Influencing My Practice Following CROI 2022—Audio Recap: Listen to expert insights from Daniel R. Kuritzkes, MD, and David A. Wohl, MD, on some of the most clinically relevant new data presented at CROI 2022, including prevention strategies, long-acting therapies, second-line therapies, comorbidities, and cure. by CCO Infectious Disease Podcast
47 min listen
Ep 29 - COVID-19 Vaccines and Derm Patients: "There really is no safety risk with any non-live vaccine to our patients on biologics. And the vast majority of studies state that the efficacy of vaccines is maintained for patients on biologic therapy."In a timely interview, by JCMS: Author Interviews & Editor's Choice with Dr Kirk Barber (Listen and earn CME credit)
37 min listen
Lit. Update with Jon Schoenecker: Dr. Jonathan Schoenecker from Vanderbilt joins the show to discuss his recent research on using CRP to manage musculoskeletal infections. This episode also covers recent research on the value of axial imaging in infections, numerous hip preservation ... by Peds Ortho
79 min listen
NEJM Interview: Douglas Krakower on the potential benefits associated with making preexposure prophylaxis for HIV available without a prescription. by NEJM Interviews
19 min listen
Phage Therapy & How to Pull Away From the Drug-Induced Illusion of Health w/Dr. David Jernigan: Human beings are biophotonic, plasmatic discharges and oscillating waves of energy. Some of the biggest physical ailments people suffer from can be solved by focusing on this truth, and treating the illness with what’s already within. This is... by The Jay Campbell Podcast
47 min listen
The Near-Term Future of Exosome Science with Capricor Therapeutics' Dr. Linda Marbán by Cell & Gene: The Podcast
28 min listen
PET/CT in Resectable Non-Small Cell Lung Cancer: Dr. Lauren Kim summarizes major take home points from "Use of Preoperative FDG PET/CT and Survival of Patients with Resectable Non-Small Cell Lung Cancer" by Dr. Wan-Ming Chen and colleagues. Dr. Heera Yeon's Radiology in Training article summary of... by Radiology Podcasts | RSNA
8 min listen

Discover this podcast and so much more

TJ Cradick Speaks About Their HIV CRISPR Therapy in Trials

TJ Cradick Speaks About Their HIV CRISPR Therapy in Trials

Description

Titles in the series (32)

More Episodes from CRISPR Cuts

Related podcast episodes